Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: A step ahead?

被引：12
|
作者：
Ilson, DH [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 08期
关键词：
D O I：
10.1200/JCO.2002.20.8.1962
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1962 / 1964
页数：3
相关论文
共 50 条
  • [21] Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance)
    Patel, Jai N.
    Jiang, Chen
    Owzar, Kouros
    Mulkey, Flora
    Luzum, Jasmine A.
    Mamon, Harvey J.
    Haller, Daniel G.
    Dragovich, Tomislav
    Alberts, Steven R.
    Bjarnason, Georg
    Willet, Christopher G.
    Niedzwiecki, Donna
    Enzinger, Peter
    Ratain, Mark J.
    Fuchs, Charles
    McLeod, Howard L.
    PHARMACOGENETICS AND GENOMICS, 2021, 31 (09): : 215 - 220
  • [22] EPIRUBICIN, CISPLATIN AND INTERMITTENT CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER - AN EFFECTIVE REGIMEN
    POORTER, RL
    BAKKER, PJM
    TAAT, CW
    BARTELSMAN, JFW
    VEENHOF, CHN
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1404 - 1404
  • [23] PHASE II TRIAL OF ENDOSTAR COMBINED WITH EPIRUBICIN, CISPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED AND METASTATIC GASTRIC CANCER
    Zhu, X.
    ANNALS OF ONCOLOGY, 2012, 23 : 19 - 19
  • [24] Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer
    Di Lauro, L
    Belli, F
    Arena, MG
    Carpano, S
    Paoletti, G
    Giannarelli, D
    Lopez, M
    ANNALS OF ONCOLOGY, 2005, 16 (09) : 1498 - 1502
  • [25] Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer
    Eisen, T
    Smith, IE
    Johnston, S
    Ellis, PA
    Prendiville, J
    Seymour, MT
    Walsh, G
    Ashley, S
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1350 - 1357
  • [26] Epirubicin, cisplatin, and protracted venous-infusion fluorouracil in advanced esophagogastric cancer
    Leonard, GD
    Zhuang, SH
    Grem, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) : 4124 - 4125
  • [27] Protracted infusion fluorouracil with epirubicin and cisplatin in prostate cancer: An active new regimen
    Chao, D
    Harland, SJ
    BRITISH JOURNAL OF CANCER, 1996, 74 : PO20 - PO20
  • [28] Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
    Webb, A
    Cunningham, D
    Scarffe, JH
    Harper, P
    Norman, A
    Joffe, JK
    Hughes, M
    Mansi, J
    Findlay, M
    Hill, A
    Oates, J
    Nicolson, M
    Hickish, T
    OBrien, M
    Iveson, T
    Watson, M
    Underhill, C
    Wardley, A
    Meehan, M
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 261 - 267
  • [29] Weekly Docetaxel, Cisplatin, and 5-Fluorouracil as Initial Therapy for Patients With Advanced Gastric and Esophageal Cancer
    Overman, Michael J.
    Kazmi, Syed M.
    Jhamb, Jagriti
    Lin, E.
    Yao, James C.
    Abbruzzese, James L.
    Ho, Linus
    Ajani, Jaffer
    Phan, Alexandria
    CANCER, 2010, 116 (06) : 1446 - 1453
  • [30] Systemic chemotherapy in advanced gastric carcinoma: a comparison of docetaxel, cisplatin and fluorouracil (DCF) versus cisplatin and fluorouracil (CF); versus epirubicin, cisplatin and fluorouracil (ECF) regimens in clinical setting, a retrospective study
    Kumari, P.
    Beniwal, S.
    Khatri, P.
    Kapoor, A.
    ANNALS OF ONCOLOGY, 2016, 27 : 90 - 90
12345